Address
Email address
Phone number
https://rosena.eeKollageen | Näohooldus | Akne ravi tooted | Juuste vitamiinid - RosenaApteegikosmeetika ja toidulisandid Euroopa tootjatelt. Meie valikus on akne ravi tooted, kollageeni toidulisandid, psoriaasi ja atoopilise dermatiidi kreemid, toidulisandid lastele, juuste vitamiinid jpm.
Name
OÜ Rosena DK
Registry code
14002345
VAT number
EE101862516
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
25.02.2016 (9)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
46451 - Wholesale of perfume and cosmetics 47911 - Retail sale via mail order houses or via Internet
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anniki Telling
| 50% - 1 250.00 EUR | Board member | - | Founder |
| Karin Telling
| 50% - 1 250.00 EUR | Board member | - | Founder |
| Ivar Järving
| - | - | - | Founder |
| Nigulas Samel
| - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 97 639.13 € | 8 306.87 € | 3 727.39 € | 4 |
| 2024 Q3 | 97 914.69 € | 5 303.79 € | 2 299.62 € | 4 |
| 2024 Q2 | 110 867.31 € | 7 946.85 € | 4 228.3 € | 4 |
| 2024 Q1 | 128 739.2 € | 14 388.76 € | 5 285.84 € | 4 |
| 2023 Q4 | 125 362.77 € | 11 689.95 € | 3 966.74 € | 4 |
| 2023 Q3 | 112 191.33 € | 11 920.99 € | 4 137.9 € | 3 |
| 2023 Q2 | 174 187.64 € | 17 633.69 € | 4 690.82 € | 3 |
| 2023 Q1 | 108 388.42 € | 15 177.6 € | 5 382.7 € | 3 |
| 2022 Q4 | 130 251.02 € | 17 059.3 € | 9 559.18 € | 4 |
| 2022 Q3 | 147 426.97 € | 21 635.48 € | 7 831.6 € | 5 |
| 2022 Q2 | 131 794.45 € | 15 845.55 € | 6 545.41 € | 5 |
| 2022 Q1 | 169 805.31 € | 17 934.63 € | 9 812.08 € | 6 |
| 2021 Q4 | 175 677.17 € | 21 919 € | 9 137.2 € | 6 |
| 2021 Q3 | 175 665.21 € | 15 866.57 € | 8 226.86 € | 7 |
| 2021 Q2 | 227 279.72 € | 14 301.31 € | 8 834.35 € | 6 |
| 2021 Q1 | 182 254.54 € | 23 367.41 € | 6 996.17 € | 6 |
| 2020 Q4 | 261 015.81 € | 21 259.36 € | 6 210.44 € | 6 |
| 2020 Q3 | 131 020.34 € | 12 769.74 € | 3 525.95 € | 5 |
| 2020 Q2 | 172 234.54 € | 13 312.12 € | 5 177.55 € | 5 |
| 2020 Q1 | 170 687.9 € | 19 874.39 € | 4 897.24 € | 6 |
